NantHealth Statistics
Total Valuation
NantHealth has a market cap or net worth of 32,600. The enterprise value is 270.84 million.
| Market Cap | 32,600 |
| Enterprise Value | 270.84M |
Important Dates
The next estimated earnings date is Monday, February 24, 2025.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NantHealth has 32.60 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 32.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +94.84% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 0.00% |
| Float | 8.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.85 |
| EV / Sales | 4.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.46 |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.64 |
| Interest Coverage | -2.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.83% |
| Return on Invested Capital (ROIC) | -58.89% |
| Return on Capital Employed (ROCE) | 87.28% |
| Revenue Per Employee | 172,314 |
| Profits Per Employee | -188,670 |
| Employee Count | 373 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.65% in the last 52 weeks. The beta is 4.93, so NantHealth's price volatility has been higher than the market average.
| Beta (5Y) | 4.93 |
| 52-Week Price Change | -99.65% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 37.07 |
| Average Volume (20 Days) | 143 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.29 |
Income Statement
In the last 12 months, NantHealth had revenue of 64.27 million and -70.37 million in losses. Loss per share was -7.37.
| Revenue | 64.27M |
| Gross Profit | 40.90M |
| Operating Income | -38.94M |
| Pretax Income | -70.64M |
| Net Income | -70.37M |
| EBITDA | -29.88M |
| EBIT | -38.94M |
| Loss Per Share | -7.37 |
Balance Sheet
The company has 5.82 million in cash and 276.63 million in debt, giving a net cash position of -270.81 million or -8.31 per share.
| Cash & Cash Equivalents | 5.82M |
| Total Debt | 276.63M |
| Net Cash | -270.81M |
| Net Cash Per Share | -8.31 |
| Equity (Book Value) | -250.18M |
| Book Value Per Share | -9.11 |
| Working Capital | -175.76M |
Cash Flow
In the last 12 months, operating cash flow was -27.64 million and capital expenditures -4.38 million, giving a free cash flow of -32.02 million.
| Operating Cash Flow | -27.64M |
| Capital Expenditures | -4.38M |
| Free Cash Flow | -32.02M |
| FCF Per Share | -0.98 |
Margins
Gross margin is 63.64%, with operating and profit margins of -60.58% and -109.49%.
| Gross Margin | 63.64% |
| Operating Margin | -60.58% |
| Pretax Margin | -109.90% |
| Profit Margin | -109.49% |
| EBITDA Margin | -46.48% |
| EBIT Margin | -60.58% |
| FCF Margin | n/a |
Dividends & Yields
NantHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.00% |
| Shareholder Yield | -24.00% |
| Earnings Yield | -215,871.17% |
| FCF Yield | -98,211.66% |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 0.0666667.
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0666667 |
Scores
NantHealth has an Altman Z-Score of -12.99. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.99 |
| Piotroski F-Score | n/a |